The benefit-risk profile of a popular cosmetic treatment will be on the agenda at a 23 March virtual meeting of the US Food and Drug Administration’s General and Plastic Surgery Devices Panel, the agency announced on 16 February.
The meeting, which will be the first for the panel since 2019, is set to focus on dermal fillers. The...






